Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Spain
  4. Bolsas y Mercados Espanoles
  5. Grifols, S.A.
  6. Company
    GRF   ES0171996087

GRIFOLS, S.A.

(GRF)
  Report
Real-time Estimate Tradegate  -  12:55 2022-09-29 pm EDT
8.740 EUR   -3.77%
09/28European ADRs Move Higher in Wednesday Trading
MT
09/27European ADRs Climb Higher in Tuesday Trading
MT
09/26Grifols Forecasts Strong Revenue Growth in H2 Amid HIgher Plasma Collection
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo Grifols, S.A.
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows:

- products derived from plasma (77.3%): products for use by the pharmaceutical and biotechnology industries;

- diagnostic machines and reagents (14.9%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers;

- hospital products (2.4%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies;

- other (5.4%): primarily intermediate biological products and subcontracted manufacturing services.

Net sales are distributed geographically as follows: Spain (7.4%), European Union (11%), the United States and Canada (63.9%) and other (17.7%).

Number of employees : 23 245 people.
Sales per Business
20202021Delta
Bioscience4 242.5079.4%3 814.9877.3% -10.08%
Diagnostic775.8914.5%779.1115.8% +0.41%
Bio Supplies224.094.2%225.774.6% +0.75%
Hospital118.682.2%141.192.9% +18.97%
Others31.990.6%39.620.8% +23.86%
EUR in Million
Sales per region
20202021Delta
United States and Canada3 599.7567.4%3 154.5563.9% -12.37%
Rest of World905.8017%872.1217.7% -3.72%
Rest of European Union495.329.3%544.0411% +9.84%
Spain339.176.4%362.417.3% +6.85%
EUR in Million
Managers
Name Title Age Since
Raimon Grifols Roura Joint Chief Executive Officer & Executive Director 58 2017
Victor Grifols Deu Joint Chief Executive Officer & Executive Director 45 2017
Alfredo Arroyo Guerra Chief Financial Officer & Vice President 64 2007
Xavier Sueiras Gil Chief Information Technology Officer 53 2018
Marilyn Rosa-Bray Chief Medical Officer & Vice President-Quality - -
Antonio Martínez Martínez President-Diagnostic Scientific, R&D 54 2020
César Cerezo Chief Medical Officer - 2021
Nuria Pascual Lapeña VP-Treasury & Investor Relations 58 -
Nuria Martín Barnés Secretary 62 2015
Tomás Dagá Gelabert Director & Vice Secretary 66 2016
Members of the board
Name Title Age Since
Víctor Grifols Roura Non-Executive Chairman 71 2017
Steven F. Mayer Independent Director 62 2012
Belén Villalonga Morenés, Dr. Independent Director 53 2013
Marla E. Salmon, Dr. Independent Director 71 2014
Iñigo Sánchez-Asiaín Mardones Lead Independent Director 58 2015
Carina Szpilka Lázaro Independent Director 53 2015
Enriqueta Felip Font, Dr. Independent Director - 2019
James Costos Independent Director 58 2020
Ramón Riera Roca Director 67 -
Tomás Dagá Gelabert Director & Vice Secretary 66 2016
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 426,129,798 291,923,856 68.5% 3,944,430 0.9% 79.8%
Stock B 0 261,425,110 256,725,326 98.2% 4,699,784 1.8%
Shareholders
NameEquities%
Grifols Roura Family 39,183,692 9.20%
Scranton Enterprises BV 34,655,622 8.13%
Grifols Gras Family 30,209,093 7.09%
Ralledor Holding Spain SL 26,224,374 6.15%
Capital Research & Management Co. (World Investors) 20,172,660 4.73%
The Vanguard Group, Inc. 8,497,273 1.99%
Norges Bank Investment Management 7,422,333 1.74%
BlackRock Fund Advisors 7,189,748 1.69%
LGT Capital Partners AG (Investment Management) 6,713,280 1.58%
Jupiter Asset Management Ltd. 5,577,887 1.31%
Holdings
NameEquities%Valuation
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. 1,766,165,808 99.9% 1,496,154,379 USD
BIOTEST AG (BIO) 19,034,074 96.2% 811,523,836 USD
Markets and indexes
- Mercado Continuo
- IBEX 35 / PEA, STOXX Europe 600, Stoxx Spain 20
Stock Exchange Codes
- Bloomberg Code :  GRF:SM
- Reuters Code :  GRF.MC
- Datastream Code :  
Company contact information
Grifols, S.A.
Parc empresarial Can Sant Joan Avenida de la Generalitat 152
ES-08174 San Cugat del Vallés, Barcelona

Phone : +34 935712200
Fax : +34 938008000
web site : http://www.grifols.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Grifols, S.A.
Connections : Grifols, S.A.